share_log

UPCOMING INVESTOR DEADLINE: Enovix Corporation F/k/a Rodgers Silicon Valley Acquisition Corp. Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit - ENVX

UPCOMING INVESTOR DEADLINE: Enovix Corporation F/k/a Rodgers Silicon Valley Acquisition Corp. Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit - ENVX

投資者截止日期:Enovix Corporation F/K/A 矽谷收購羅傑斯股份有限公司重大損失的投資人有機會領導集體訴訟-ENVX
newsfile ·  2023/02/23 06:10

San Diego, California--(Newsfile Corp. - February 22, 2023) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Enovix Corporation f/k/a Rodgers Silicon Valley Acquisition Corp. (NASDAQ: ENVX) common stock between February 22, 2021 and January 3, 2023, inclusive (the "Class Period") have until March 7, 2023 to seek appointment as lead plaintiff in the Enovix class action lawsuit. Captioned Twitchell v. Enovix Corporation, No. 23-cv-00071 (N.D. Cal.), the Enovix class action lawsuit charges Enovix as well as certain of its top executives with violations of the Securities Exchange Act of 1934. A subsequently filed complaint, Rosin v. Enovix Corporation, No. 23-00372, is also pending in the Northern District of California.

加利福尼亞州聖地亞哥-(Newsfile Corp.-2023年2月22日)-Robbins Geller Rudman&Dowd LLP宣佈在2021年2月22日至2023年1月3日(首尾兩天包括在內)之間(包括首尾兩天)購買Enovix Corporation f/k/a羅傑斯硅谷收購公司(Enovix Corporation f/k/a Rodgers Silicon Acquisition Corp.)普通股的購買人或收購人可以在2023年3月7日之前尋求被任命為Enovix集體訴訟。標題Twitchell訴Enovix公司案,編號23-cv-00071(北加州),Enovix集體訴訟起訴Enovix以及它的某些高管違反了1934年的《證券交易法》。隨後提出了申訴,Rosin訴Enovix公司案,編號23-00372,也在加州北區懸而未決。

If you suffered substantial losses and wish to serve as lead plaintiff of the Enovix class action lawsuit, please provide your information here:

如果你遭受了重大損失,並希望擔任Enovix集體訴訟,請在此處提供您的信息:

You can also contact attorney J.C. Sanchez of Robbins Geller by calling 800/449-4900 or via e-mail at jsanchez@rgrdlaw.com.

你也可以聯繫律師J.C.桑切斯 通過撥打800/449-4900或發送電子郵件至郵箱:jsanchez@rgrdlaw.com.

CASE ALLEGATIONS: Enovix purports to design, develop, and manufacture silicon-anode lithium-ion batteries using proprietary 3D cell architecture, which Enovix claims allows its batteries to achieve higher energy density. On July 14, 2021, Enovix was officially acquired by Rodgers Silicon Valley Acquisition Corp., a special purpose acquisition company (commonly known as a SPAC or blank-check company). Just months before the merger, Enovix received key equipment to establish its first manufacturing line at its "Fab-1" facility in Fremont, California.

案件指控:Enovix聲稱使用專有的3D電池架構設計、開發和製造硅陽極鋰離子電池,Enovix聲稱這使其電池能夠實現更高的能量密度。2021年7月14日,Enovix被羅傑斯硅谷收購公司正式收購,羅傑斯硅谷收購公司是一家特殊目的收購公司(俗稱SPAC或空白支票公司)。就在合併前幾個月,Enovix收到了關鍵設備,在其位於加利福尼亞州弗裏蒙特的“Fab-1”工廠建立了第一條生產線。

The Enovix class action lawsuit alleges that, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose material adverse facts about Enovix's revenue and ability to manufacture its proprietary battery technology. For example, as the Enovix class action lawsuit alleges, Fab-1's supposedly "automated" manufacturing lines were beset by problems that required significant manual intervention to produce batteries. In addition, machines that were meant to yield 550 batteries per hour could only complete around 100.

這個Enovix集體訴訟稱,在整個集團期間,被告作出虛假和/或誤導性陳述和/或未能披露有關Enovix收入和製造其專有電池技術能力的重大不利事實。例如,作為Enovix集體訴訟稱,FAB-1所謂的“自動化”生產線受到問題的困擾,需要大量人工幹預才能生產電池。此外,原本打算每小時生產550塊電池的機器只能完成大約100塊電池。

On November 1, 2022, Enovix announced it realized just $8,000 in revenue for the third quarter of fiscal year 2022. Enovix also revealed that it would be "dialing back" its work on improving existing manufacturing lines to focus on its future manufacturing lines. Additionally, Enovix revealed it anticipated producing fewer than one million batteries in 2023. On this news, Enovix's stock price declined approximately 44%.

2022年11月1日,Enovix宣佈2022財年第三季度收入僅為8000美元。Enovix還透露,將“縮減”改善現有生產線的工作,專注於未來的生產線。此外,Enovix透露,預計2023年電池產量不到100萬塊。消息傳出後,Enovix的股價下跌了約44%。

Then, on January 3, 2023, defendant Thurman J. Rogers, Enovix's Executive Chairman, revealed that Enovix's second production facility and future manufacturing lines would be delayed by several additional months because of equipment failures. On this news, Enovix's stock price declined an additional 41%, further damaging investors.

2023年1月3日,被告、Enovix執行主席瑟曼·J·羅傑斯透露,由於設備故障,Enovix的第二個生產設施和未來的生產線將再推遲幾個月。消息傳出後,Enovix的股價進一步下跌了41%,進一步損害了投資者的利益。

Robbins Geller has launched a dedicated SPAC Task Force to protect investors in blank check companies and seek redress for corporate malfeasance. Comprised of experienced litigators, investigators, and forensic accountants, the SPAC Task Force is dedicated to rooting out and prosecuting fraud on behalf of injured SPAC investors. The rise in blank check financing poses unique risks to investors. Robbins Geller's SPAC Task Force represents the vanguard of ensuring integrity, honesty, and justice in this rapidly developing investment arena.

羅賓斯·蓋勒推出了一個專門的SPAC特別工作組保護空白支票公司的投資者,併為公司的瀆職行為尋求補償。SPAC特別工作組由經驗豐富的訴訟律師、調查人員和法醫會計師組成,致力於根除並代表受傷的SPAC投資者起訴欺詐行為。空白支票融資的興起給投資者帶來了獨特的風險。羅賓斯·蓋勒的SPAC特別工作組代表着在這個快速發展的投資領域確保誠信、誠實和正義的先鋒。

THE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased or acquired Enovix common stock during the Class Period to seek appointment as lead plaintiff in the Enovix class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the Enovix class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the Enovix class action lawsuit. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the Enovix class action lawsuit.

主要原告程序:1995年《私人證券訴訟改革法》允許任何在類期間購買或收購Enovix普通股的投資者尋求被任命為Enovix集體訴訟。主要原告通常是在被推定的階級所尋求的救濟中具有最大經濟利益的動作者,他也是被推定的階級中的典型和適當的。主要原告代表所有其他班級成員指示Enovix集體訴訟。首席原告可以選擇其選擇的律師事務所對Enovix集體訴訟。投資者在未來任何潛在復甦中分享的能力並不取決於作為Enovix集體訴訟。

ABOUT ROBBINS GELLER: Robbins Geller is one of the world's leading complex class action firms representing plaintiffs in securities fraud cases. The Firm is ranked #1 on the most recent ISS Securities Class Action Services Top 50 Report for recovering nearly $2 billion for investors in 2021 – more than triple the amount recovered by any other plaintiffs' firm. With 200 lawyers in 9 offices, Robbins Geller is one of the largest plaintiffs' firms in the world, and the Firm's attorneys have obtained many of the largest securities class action recoveries in history, including the largest securities class action recovery ever – $7.2 billion – in In re Enron Corp. Sec. Litig. Please visit the following page for more information:

關於羅賓斯·蓋勒:Robbins Geller是世界領先的複雜集體訴訟公司之一,在證券欺詐案件中代表原告。在最新的ISS證券集體訴訟服務50強報告中,該公司因在2021年為投資者追回近20億美元而排名第一--是其他原告公司追回的金額的三倍多。羅賓斯·蓋勒在9個辦公室擁有200名律師,是世界上最大的原告律師事務所之一,該律師事務所的律師獲得了歷史上許多最大的證券集體訴訟追回,包括有史以來最大的證券集體訴訟追回-72億美元-在安然公司,美國證券交易委員會。利蒂格。有關更多信息,請訪問以下頁面:

Attorney advertising.
Past results do not guarantee future outcomes.
Services may be performed by attorneys in any of our offices.

律師廣告。
過去的結果並不能保證未來的結果。
服務可以由我們任何辦公室的律師執行。

Contact:
Robbins Geller Rudman & Dowd LLP
655 W. Broadway, Suite 1900, San Diego, CA 92101
J.C. Sanchez, 800-449-4900
jsanchez@rgrdlaw.com

聯繫方式:
Robbins Geller Rudman&Dowd LLP
655 W.百老匯,1900年套房,加州聖地亞哥,92101
J.C.桑切斯,800-449-4900
郵箱:jsanchez@rgrdlaw.com

To view the source version of this press release, please visit

要查看本新聞稿的源版本,請訪問

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論